During the past decade, Bay Area Retina Associates conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 16 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bay Area Retina Associates" #1 sponsor was "Jaeb Center for Health Research" with 11 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Ribomic USA Inc" with 3 trials sponsored and "Apellis Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bay Area Retina Associates" #1 collaborator was "National Eye Institute (NEI)" with 11 trials as a collaborator, "Allergan" with 5 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "Bay Area Retina Associates" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Bay Area Retina Associates" are "Diabetic Macular Edema" (15 trials), "Geographic Atrophy" (5 trials), "Age-Related Macular Degeneration" (3 trials), "Diabetic Retinopathy" (3 trials) and "Proliferative Diabetic Retinopathy" (3 trials). Many other conditions were trialed in "Bay Area Retina Associates" in a lesser frequency.

Most popular intervention types in "Bay Area Retina Associates" are "Drug" (37 trials), "Other" (9 trials), "Procedure" (7 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (9 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Faricimab" (4 trials) and "Sham injection" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bay Area Retina Associates" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Bay Area Retina Associates". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Bay Area Retina Associates, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Bay Area Retina Associates, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".